Drugs / Autologous induced neural stem cell-derived DA precursor cells
Autologous induced neural stem cell-derived DA precursor cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05901818 | Apr 2021 → Dec 2027 expected | Parkinson disease | Xuanwu Hospital, Beijing | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Autologous induced neural stem cell-derived DA precursor cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05901818 ↗ |
| Route | Other | “stereotactically implanted into the striatum” NCT05901818 ↗ |